271 related articles for article (PubMed ID: 23685068)
1. The prospects and challenges of universal vaccines for influenza.
Subbarao K; Matsuoka Y
Trends Microbiol; 2013 Jul; 21(7):350-8. PubMed ID: 23685068
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
[TBL] [Abstract][Full Text] [Related]
3. Universal influenza vaccines, science fiction or soon reality?
de Vries RD; Altenburg AF; Rimmelzwaan GF
Expert Rev Vaccines; 2015; 14(10):1299-301. PubMed ID: 26104835
[TBL] [Abstract][Full Text] [Related]
4. Vaccine approaches conferring cross-protection against influenza viruses.
Vemula SV; Sayedahmed EE; Sambhara S; Mittal SK
Expert Rev Vaccines; 2017 Nov; 16(11):1141-1154. PubMed ID: 28925296
[TBL] [Abstract][Full Text] [Related]
5. Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity.
Wheatley AK; Kent SJ
Expert Rev Vaccines; 2015; 14(9):1227-39. PubMed ID: 26175180
[TBL] [Abstract][Full Text] [Related]
6. Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine.
Fox A; Quinn KM; Subbarao K
Drugs; 2018 Sep; 78(13):1297-1308. PubMed ID: 30088204
[TBL] [Abstract][Full Text] [Related]
7. Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.
Sun X; Belser JA; Pulit-Penaloza JA; Creager HM; Guo Z; Jefferson SN; Liu F; York IA; Stevens J; Maines TR; Jernigan DB; Katz JM; Levine MZ; Tumpey TM
Virology; 2017 Aug; 508():164-169. PubMed ID: 28554058
[TBL] [Abstract][Full Text] [Related]
8. Strategies towards universal pandemic influenza vaccines.
He F; Leyrer S; Kwang J
Expert Rev Vaccines; 2016; 15(2):215-25. PubMed ID: 26641724
[TBL] [Abstract][Full Text] [Related]
9. Influenza vaccination in pediatric age.
Esposito S; Principi N
Expert Rev Vaccines; 2015 Jun; 14(6):785-7. PubMed ID: 25872557
[TBL] [Abstract][Full Text] [Related]
10. Virus-vectored influenza virus vaccines.
Tripp RA; Tompkins SM
Viruses; 2014 Aug; 6(8):3055-79. PubMed ID: 25105278
[TBL] [Abstract][Full Text] [Related]
11. DNA-based influenza vaccines as immunoprophylactic agents toward universality.
Zhang H; El Zowalaty ME
Future Microbiol; 2016; 11(1):153-64. PubMed ID: 26673424
[TBL] [Abstract][Full Text] [Related]
12. Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity.
Budimir N; Huckriede A; Meijerhof T; Boon L; Gostick E; Price DA; Wilschut J; de Haan A
PLoS One; 2012; 7(1):e30898. PubMed ID: 22303469
[TBL] [Abstract][Full Text] [Related]
13. Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades.
Bragstad K; Martel CJ; Thomsen JS; Jensen KL; Nielsen LP; Aasted B; Fomsgaard A
Influenza Other Respir Viruses; 2011 Jan; 5(1):13-23. PubMed ID: 21138536
[TBL] [Abstract][Full Text] [Related]
14. Novel Platforms for the Development of a Universal Influenza Vaccine.
Kumar A; Meldgaard TS; Bertholet S
Front Immunol; 2018; 9():600. PubMed ID: 29628926
[TBL] [Abstract][Full Text] [Related]
15. A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus.
Wu CY; Yeh YC; Chan JT; Yang YC; Yang JR; Liu MT; Wu HS; Hsiao PW
PLoS One; 2012; 7(8):e42363. PubMed ID: 22879951
[TBL] [Abstract][Full Text] [Related]
16. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
Walz L; Kays SK; Zimmer G; von Messling V
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
[TBL] [Abstract][Full Text] [Related]
17. Novel viral vectored vaccines for the prevention of influenza.
Lambe T
Mol Med; 2012 Oct; 18(1):1153-60. PubMed ID: 22735755
[TBL] [Abstract][Full Text] [Related]
18. Universal Influenza Vaccines: Progress in Achieving Broad Cross-Protection In Vivo.
Epstein SL
Am J Epidemiol; 2018 Dec; 187(12):2603-2614. PubMed ID: 30084906
[TBL] [Abstract][Full Text] [Related]
19. Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infections.
Tseng YC; Wu CY; Liu ML; Chen TH; Chiang WL; Yu YH; Jan JT; Lin KI; Wong CH; Ma C
Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4200-4205. PubMed ID: 30782805
[TBL] [Abstract][Full Text] [Related]
20. Targeting Hemagglutinin: Approaches for Broad Protection against the Influenza A Virus.
Zhang Y; Xu C; Zhang H; Liu GD; Xue C; Cao Y
Viruses; 2019 Apr; 11(5):. PubMed ID: 31052339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
